Skip to content

Analysis of diagnostic accuracy of predictive biomarkers in risk assessment of threatening preterm birth

Analysis of diagnostic accuracy of predictive biomarkers in risk assessment of threatening preterm birth - ADAPROB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010763
Enrollment
160
Registered
2016-09-02
Start date
2017-01-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

O60 O34.3

Interventions

Group 1: Collection of a cervicovaginal fluid (CVF) swab in case of threatened preterm birth. Placement of the swab in 500µl buffer solution with extraction of the CVF. Quantitative measurement of of

Sponsors

Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt Rostock
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pregnant women with singleton pregnancy between 22+0 and 31+6 weeks of gestation. Age > 18 years with signs or symptoms of threatened preterm birth: regular (>3/30min) and/or painful uterine contractions, shortening of the cervix <25mm

Exclusion criteria

Exclusion criteria: Opening of the cervix >3cm, cerclage suture in situ, intravaginal placement of a pessary, maternal temperature >37.5°C, preterm rupture of membranes, vaginal bleeding, vaginal examination or transvaginal ultrasound during the last 6 hours, sexual intercourse during the last 24 hours, vaginal pH =5.0, multiple pregnancy, tocolysis during the last 7 days, hypertensive pregnancy disorder, necessity of iatrogenic indicated delivery in the next 7 days.

Design outcomes

Primary

MeasureTime frame
Test characteristics of the investigated biomarkers in respect to the frequency of preterm birth < 32+0 weeks of gestation

Secondary

MeasureTime frame
Test characteristics of the investigated biomarkers in respect to the frequency of preterm birth < 37+0 weeks of gestation and time interval between diagnosis and delivery, occurrence of severe neonatal morbidity (necrotizing enterocolitis, intraventricular hemorrhage, grade III and IV, bronchopulmonary dysplasia, sepsis) and mortalitiy.

Countries

Germany

Contacts

Public ContactJohannes Stubert

Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt Rostock

johannes.stubert@uni-rostock.de038144018475

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026